← All stocks

Aclaris Therapeutics, Inc.

ACRS Net selling
CIK 0001557746 #2604 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.36M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.36M
1 of 1 sales
Net
−$1.36M
−$1.36M against sales at will

By person

14 insiders · 1 transaction
11.3×

Neal Walker holds 11.3 times base salary in stock. $6.99M of shares against $615.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Neal Walker last reported holding, valued at $4.53, the price Common Stock was last bought or sold at on the open market here, on 23 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Leonard Braden Michael
10% owner
$1.36M (1)
−$1.36M
13,950,000
$63.19M
−2.1%
Walker Neal
CEO
1,543,886
$6.99M
+13.3%
Mehra Anand
Director
726,403
$3.29M
+1,575%
Monahan Joseph
Chief Scientific Officer
265,662
$1.20M
+42.2%
Loerop James
Chief Business Officer
192,260
$870.94K
+166.0%
Balthaser Kevin
Chief Financial Officer
187,453
$849.16K
+659.0%
Molineaux Christopher P.
Director
69,536
$315.00K
+30.8%
Davis Hugh M.
President and COO
45,425
$205.78K
Humphries William D.
Director
45,105
$204.33K
+57.0%
GOWEN MAXINE
Director
33,334
$151.00K
+96.5%
MILANO VINCENT
Director
28,896
$130.90K
+130.7%
Hall Jesse Wayne
Chief Medical Officer
27,045
$122.51K
SCHIFF ANDREW N
Director
25,540
$115.70K
+178.6%
Kolbeck Roland Wilhelm
Chief Scientific Officer
23,990
$108.67K

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 71,430,942 to 147,198,893 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Leonard Braden Michael
23 Apr 2026
10% owner
Sell indirect
300,000
$4.53
$1.36M

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 661,790
History held since 31 Aug 2016